American Bio Medica Corp logo

American Bio Medica Corp

$ 0.02 -0.00195 (-9.75%) 09:30 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 868.00K
Enterprise V:
$ 2.40M
Volume:
800.00
Avg Vol (2M):
22.24K
Volume:
800.00
Market Cap $:
868.00K
PE Ratio:
At Loss
Avg Vol (2-Month):
22.24K
Enterprise Value $:
2.40M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

American Bio Medica Corp
NAICS : 541380 SIC : 8071
Description
American Bio Medica Corp is a US-based company engaged in manufacturing and selling lateral flow immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids at the point of collection. It also manufactures and sells drug testing products and provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. The company offers few urine tests which include Rapid Drug Screen, RDS InCup, Rapid TOX, and Rapid TOX Cup II. Its target customer includes workplace, government, corrections, clinical and educational markets. Geographically, it derives a majority of revenue from the United States.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset -1.36
Debt-to-Equity -0.9
Debt-to-EBITDA -8.37
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -28.66
Distress
Grey
Safe
Beneish M-Score -7.06
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 47.78
9-Day RSI 44.23
14-Day RSI 44.49
6-1 Month Momentum % -0.64
12-1 Month Momentum % -36.73

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.25
Quick Ratio 0.12
Days Inventory 112.79
Days Sales Outstanding 100.15
Days Payable 191.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.8

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 15.85
Operating Margin % -66.55
Net Margin % -26.58
ROA % -25.57
ROIC % -48.61
ROC (Joel Greenblatt) % -45.82

Financials

ABMC's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ABMC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.659
EPS (TTM) ($) -0.006
Beta -1.39
Volatility % 89.96
14-Day RSI 44.49
14-Day ATR ($) 0.003188
20-Day SMA ($) 0.021629
12-1 Month Momentum % -36.73
52-Week Range ($) 0.017 - 0.099
Shares Outstanding (Mil) 48.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

American Bio Medica Corp Filings

Document Form Filing Date
No Filing Data

American Bio Medica Corp Analysis

Share your research

Headlines

See More
No news.